Oncolytic virotherapy using coxsackie virus
10 Oct 2016
Oncolytic virotherapy using coxsackie virus
Results of the Activ8 trial of novel immunotherapy motolimod
Lurbinectedin in PARP resistant breast cancer
Monitoring patterns of care in mCRPC patients with the help of the Cancer Registry
Lurbinectedin in BRCA 1/2 breast cancer
Olaparib and paclitaxel for 2nd line gastric cancer therapy
Comment: Ipilimumab in high risk stage III melanoma
Comment: Ribociclib for breast cancer
Treating CNS metastases from breast cancer with a peptide/paclitaxel conjugate
Highlights of ESMO 2016
Adjuvant sunitinib for renal cell carcinoma
Longer disease-free survival in phase III trial of sunitinib as adjuvant treatment for kidney cancer